Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients

Treatment resistance (TR) in psychosis is a major clinical problem. A biomarker predicting TR against conventional antipsychotic drugs would be relevant, potentially reducing unnecessary delay to adequate treatment with clozapine. Dopa decarboxylase (DDC) activity in the striatum, measured with posi...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Pluijm, Marieke, Sutterland, Arjen L., van Kuilenburg, André B. P., Zoetekouw, Lida, de Haan, Lieuwe, Booij, Jan, van de Giessen, Elsmarieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732859/
https://www.ncbi.nlm.nih.gov/pubmed/31523419
http://dx.doi.org/10.1177/2045125319872341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732859/
https://www.ncbi.nlm.nih.gov/pubmed/31523419
http://dx.doi.org/10.1177/2045125319872341

Ejemplares similares